Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management of high-grade lymphomas

I T Magrath1

  • 1Lymphoma Biology Section, National Cancer Institute, Bethesda, Maryland, USA.

Oncology (Williston Park, N.Y.)
|November 27, 1998
PubMed
Summary

High-grade non-Hodgkin's lymphomas, including Burkitt lymphoma, have poor adult prognoses. Pediatric treatment strategies show promise for improving adult survival rates in these aggressive lymphomas.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Burkitt's/Burkitt's-like lymphoma presenting as bacterial sinusitis in two HIV-infected children.

AIDS patient care and STDs·2001
Same author

Increased level of stromal cell-derived factor-1 mRNA in peripheral blood mononuclear cells from children with AIDS-related lymphoma.

Cancer research·2001
Same author

Expression of EBV encoded nuclear small non-polyadenylated RNA (EBER) molecules in 32 cases of childhood Burkitt's lymphoma from Israel.

Leukemia & lymphoma·2001
Same author

Loss of Y chromosome in bilharzial bladder cancer.

Cancer genetics and cytogenetics·2000
Same author

Molecular profile of Epstein-Barr virus infection in HHV-8-positive primary effusion lymphoma.

Leukemia·2000
Same author

Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: high prevalence of p53 overexpression.

Human pathology·1999

Area of Science:

  • Oncology
  • Hematology
  • Clinical Medicine

Background:

  • High-grade non-Hodgkin's lymphomas (NHL) historically included subtypes with poor prognoses.
  • These subtypes were immunoblastic lymphoma, lymphoblastic lymphoma, and small-noncleaved-cell lymphoma.
  • Small-noncleaved-cell lymphoma further divided into Burkitt's and non-Burkitt's lymphoma.

Purpose of the Study:

  • To discuss the management of Burkitt, Burkitt-like, and lymphoblastic lymphomas.
  • To explore the potential for improving adult survival rates.
  • To evaluate the application of pediatric treatment strategies in adult patients.

Main Methods:

  • Review of current treatment strategies for high-grade lymphomas.
  • Analysis of survival rates in pediatric patients treated with intensive protocols.
  • Comparison of adult and pediatric treatment outcomes.

Main Results:

  • Adult treatment for high-grade lymphomas remains challenging with unfavorable outcomes.
  • Pediatric patients achieve high survival rates (80%-90%) with intensive, short-duration protocols.
  • The study discusses the potential transferability of these pediatric protocols to adult cases.

Conclusions:

  • Intensive treatment protocols successful in children may offer improved survival for adults with Burkitt, Burkitt-like, and lymphoblastic lymphomas.
  • Further research is warranted to validate these pediatric-inspired strategies in adult populations.
  • Optimizing management of aggressive NHL subtypes in adults is a critical clinical goal.

Related Experiment Videos